人工知能による医薬品開発の世界市場インサイト、2029年までの予測Global Artificial Intelligence Drug Development Market Insights, Forecast to 2029 市場分析と洞察:人工知能医薬品開発の世界市場 人工知能医薬品開発の世界市場は、予測期間中に年平均成長率(CAGR)%で、2023年の百万米ドルから2029年には百万米ドルに成長すると予測されます。 人工知能医薬... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー市場分析と洞察:人工知能医薬品開発の世界市場人工知能医薬品開発の世界市場は、予測期間中に年平均成長率(CAGR)%で、2023年の百万米ドルから2029年には百万米ドルに成長すると予測されます。 人工知能医薬品開発の米国・カナダ市場は、2023年の100万ドルから2029年には100万ドルに達すると予測され、2023年から2029年の予測期間中にCAGR %で増加すると予測されます。 人工知能医薬品開発の中国市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年の予測期間中にCAGR %で増加すると考えられています。 人工知能医薬品開発のヨーロッパ市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年の予測期間中にCAGR %で増加する。 人工知能医薬品開発の世界の主要企業は、Insilico Medicine、Cyclica、XtalPi Inc.、Exscientia Limited、AiCure, LLC、Atomwise、Biovista Inc.、Breg,Inc.、Numerateなど、2022年には世界の上位5社が収益面で約 %のシェアを占めていました。 レポートの内容 本レポートでは、人工知能による医薬品開発の世界市場規模を概観します。2018年~2022年の過去の市場収益データ、2023年の予測、2029年までのCAGRの予測など、世界市場動向の分析を行っています。 人工知能医薬品開発の主要生産者を調査し、主要地域と国の収益も提供します。人工知能医薬品開発の今後の市場可能性のハイライトと、この市場を様々なセグメントとサブセグメントに分けて予測するための主要地域/国の注目点。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データおよび市場価値分析。 本レポートでは、2018年から2023年のデータで、主要企業の人工知能医薬品開発の収益、市場シェア、業界ランキングに焦点を当てています。世界の人工知能医薬品開発市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、関係者が競争環境を理解し、より多くの洞察を得て、事業や市場戦略をより良い形で位置づけるのに役立つと思われます。 本レポートでは、2018年から2029年までの、タイプ別、用途別のセグメントデータ、収益、成長率を分析しています。人工知能医薬品開発の収益、予測される成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。 Insilico Medicine、Cyclica、XtalPi Inc.、Exscientia Limited、AiCure, LLC、Atomwise、Biovista Inc.、Breg,Inc.、Numerateなど、世界の主要企業の詳細な会社プロファイル。 会社別 インシリコメディシン サイリカ XtalPi Inc. エクスセンシア・リミテッド アイキュアLLC アトムワイズ バイオビスタ・インコーポレイテッド Breg,Inc. ヌメレート クラウド・ファーマシューティカルズ IBM NuMedii ベネボレントAI ラム・セラピューティクス タイプ別セグメント ドラッグデザイン 薬物合成 その他 アプリケーション別セグメント 腫瘍 神経系 その他 地域別 北アメリカ 米国 カナダ ヨーロッパ ドイツ フランス 英国 イタリア ロシア 北欧諸国 その他のヨーロッパ アジア・パシフィック 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア 中南米 メキシコ ブラジル ラテンアメリカの残りの地域 中近東・アフリカ・中南米 トルコ サウジアラビア UAE MEAの残りの地域 各章の概要 第1章:報告書のスコープ、異なる市場セグメント(製品タイプ、アプリケーションなど)のエグゼクティブサマリー、各市場セグメントの市場規模、将来の発展可能性などを紹介します。市場の現状と、短・中期・長期的にどのような進化を遂げる可能性があるのかについて、ハイレベルな視点で解説しています。 第2章 人工知能医薬品開発の世界レベル、地域レベルの売上高各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来の発展見通し、市場スペース、生産能力などを紹介しています。また、市場力学、市場の最新動向、市場の推進要因と制限要因、業界各社が直面する課題とリスク、業界の関連政策の分析などを紹介します。 第3章:人工知能医薬品開発企業の競争環境、収益、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。 第4章:各種市場セグメントをタイプ別に分析し、各市場セグメントの収益、発展可能性を網羅し、読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけるのに役立つ情報を提供する。 第5章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの収益、開発可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。 第6章:北米:タイプ別、アプリケーション別、国別、各セグメント別の収益。 第7章:ヨーロッパ:タイプ別、アプリケーション別、国別、各セグメントごとの収益。 第8章:中国 タイプ別、アプリケーション別、セグメント別の収益。 第9章:アジア(中国を除く) タイプ別、アプリケーション別、地域別、各セグメントごとの収益。 第10章 中東、アフリカ、中南米 タイプ別、アプリケーション別、国別、各セグメントごとの収益。 第11章:主要企業のプロフィールを提供し、製品の説明や仕様、人工知能医薬品開発の収益、粗利益率、最近の開発など、市場の主要企業の基本状況を詳細に紹介する。 第12章 アナリストの視点/結論 目次1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Artificial Intelligence Drug Development Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 Drug Design 1.2.3 Drug Synthesis 1.2.4 Other 1.3 Market by Application 1.3.1 Global Artificial Intelligence Drug Development Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Tumor 1.3.3 Nervous System 1.3.4 Other 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Artificial Intelligence Drug Development Market Perspective (2018-2029) 2.2 Global Artificial Intelligence Drug Development Growth Trends by Region 2.2.1 Artificial Intelligence Drug Development Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Artificial Intelligence Drug Development Historic Market Size by Region (2018-2023) 2.2.3 Artificial Intelligence Drug Development Forecasted Market Size by Region (2024-2029) 2.3 Artificial Intelligence Drug Development Market Dynamics 2.3.1 Artificial Intelligence Drug Development Industry Trends 2.3.2 Artificial Intelligence Drug Development Market Drivers 2.3.3 Artificial Intelligence Drug Development Market Challenges 2.3.4 Artificial Intelligence Drug Development Market Restraints 3 Competition Landscape by Key Players 3.1 Global Revenue Artificial Intelligence Drug Development by Players 3.1.1 Global Artificial Intelligence Drug Development Revenue by Players (2018-2023) 3.1.2 Global Artificial Intelligence Drug Development Revenue Market Share by Players (2018-2023) 3.2 Global Artificial Intelligence Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Global Key Players of Artificial Intelligence Drug Development, Ranking by Revenue, 2021 VS 2022 VS 2023 3.4 Global Artificial Intelligence Drug Development Market Concentration Ratio 3.4.1 Global Artificial Intelligence Drug Development Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Drug Development Revenue in 2022 3.5 Global Key Players of Artificial Intelligence Drug Development Head office and Area Served 3.6 Global Key Players of Artificial Intelligence Drug Development, Product and Application 3.7 Global Key Players of Artificial Intelligence Drug Development, Date of Enter into This Industry 3.8 Mergers & Acquisitions, Expansion Plans 4 Artificial Intelligence Drug Development Breakdown Data by Type 4.1 Global Artificial Intelligence Drug Development Historic Market Size by Type (2018-2023) 4.2 Global Artificial Intelligence Drug Development Forecasted Market Size by Type (2024-2029) 5 Artificial Intelligence Drug Development Breakdown Data by Application 5.1 Global Artificial Intelligence Drug Development Historic Market Size by Application (2018-2023) 5.2 Global Artificial Intelligence Drug Development Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Artificial Intelligence Drug Development Market Size (2018-2029) 6.2 North America Artificial Intelligence Drug Development Market Size by Type 6.2.1 North America Artificial Intelligence Drug Development Market Size by Type (2018-2023) 6.2.2 North America Artificial Intelligence Drug Development Market Size by Type (2024-2029) 6.2.3 North America Artificial Intelligence Drug Development Market Share by Type (2018-2029) 6.3 North America Artificial Intelligence Drug Development Market Size by Application 6.3.1 North America Artificial Intelligence Drug Development Market Size by Application (2018-2023) 6.3.2 North America Artificial Intelligence Drug Development Market Size by Application (2024-2029) 6.3.3 North America Artificial Intelligence Drug Development Market Share by Application (2018-2029) 6.4 North America Artificial Intelligence Drug Development Market Size by Country 6.4.1 North America Artificial Intelligence Drug Development Market Size by Country: 2018 VS 2022 VS 2029 6.4.2 North America Artificial Intelligence Drug Development Market Size by Country (2018-2023) 6.4.3 North America Artificial Intelligence Drug Development Market Size by Country (2024-2029) 6.4.4 United States 6.4.5 Canada 7 Europe 7.1 Europe Artificial Intelligence Drug Development Market Size (2018-2029) 7.2 Europe Artificial Intelligence Drug Development Market Size by Type 7.2.1 Europe Artificial Intelligence Drug Development Market Size by Type (2018-2023) 7.2.2 Europe Artificial Intelligence Drug Development Market Size by Type (2024-2029) 7.2.3 Europe Artificial Intelligence Drug Development Market Share by Type (2018-2029) 7.3 Europe Artificial Intelligence Drug Development Market Size by Application 7.3.1 Europe Artificial Intelligence Drug Development Market Size by Application (2018-2023) 7.3.2 Europe Artificial Intelligence Drug Development Market Size by Application (2024-2029) 7.3.3 Europe Artificial Intelligence Drug Development Market Share by Application (2018-2029) 7.4 Europe Artificial Intelligence Drug Development Market Size by Country 7.4.1 Europe Artificial Intelligence Drug Development Market Size by Country: 2018 VS 2022 VS 2029 7.4.2 Europe Artificial Intelligence Drug Development Market Size by Country (2018-2023) 7.4.3 Europe Artificial Intelligence Drug Development Market Size by Country (2024-2029) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 China 8.1 China Artificial Intelligence Drug Development Market Size (2018-2029) 8.2 China Artificial Intelligence Drug Development Market Size by Type 8.2.1 China Artificial Intelligence Drug Development Market Size by Type (2018-2023) 8.2.2 China Artificial Intelligence Drug Development Market Size by Type (2024-2029) 8.2.3 China Artificial Intelligence Drug Development Market Share by Type (2018-2029) 8.3 China Artificial Intelligence Drug Development Market Size by Application 8.3.1 China Artificial Intelligence Drug Development Market Size by Application (2018-2023) 8.3.2 China Artificial Intelligence Drug Development Market Size by Application (2024-2029) 8.3.3 China Artificial Intelligence Drug Development Market Share by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia Artificial Intelligence Drug Development Market Size (2018-2029) 9.2 Asia Artificial Intelligence Drug Development Market Size by Type 9.2.1 Asia Artificial Intelligence Drug Development Market Size by Type (2018-2023) 9.2.2 Asia Artificial Intelligence Drug Development Market Size by Type (2024-2029) 9.2.3 Asia Artificial Intelligence Drug Development Market Share by Type (2018-2029) 9.3 Asia Artificial Intelligence Drug Development Market Size by Application 9.3.1 Asia Artificial Intelligence Drug Development Market Size by Application (2018-2023) 9.3.2 Asia Artificial Intelligence Drug Development Market Size by Application (2024-2029) 9.3.3 Asia Artificial Intelligence Drug Development Market Share by Application (2018-2029) 9.4 Asia Artificial Intelligence Drug Development Market Size by Region 9.4.1 Asia Artificial Intelligence Drug Development Market Size by Region: 2018 VS 2022 VS 2029 9.4.2 Asia Artificial Intelligence Drug Development Market Size by Region (2018-2023) 9.4.3 Asia Artificial Intelligence Drug Development Market Size by Region (2024-2029) 9.4.4 Japan 9.4.5 South Korea 9.4.6 China Taiwan 9.4.7 Southeast Asia 9.4.8 India 9.4.9 Australia 10 Middle East, Africa, and Latin America 10.1 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size (2018-2029) 10.2 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Type 10.2.1 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Type (2018-2023) 10.2.2 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Type (2024-2029) 10.2.3 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Share by Type (2018-2029) 10.3 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Application 10.3.1 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Application (2018-2023) 10.3.2 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Application (2024-2029) 10.3.3 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Share by Application (2018-2029) 10.4 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Country 10.4.1 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Country: 2018 VS 2022 VS 2029 10.4.2 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Country (2018-2023) 10.4.3 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Country (2024-2029) 10.4.4 Brazil 10.4.5 Mexico 10.4.6 Turkey 10.4.7 Saudi Arabia 10.4.8 Israel 10.4.9 GCC Countries 11 Key Players Profiles 11.1 Insilico Medicine 11.1.1 Insilico Medicine Company Details 11.1.2 Insilico Medicine Business Overview 11.1.3 Insilico Medicine Artificial Intelligence Drug Development Introduction 11.1.4 Insilico Medicine Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.1.5 Insilico Medicine Recent Developments 11.2 Cyclica 11.2.1 Cyclica Company Details 11.2.2 Cyclica Business Overview 11.2.3 Cyclica Artificial Intelligence Drug Development Introduction 11.2.4 Cyclica Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.2.5 Cyclica Recent Developments 11.3 XtalPi Inc. 11.3.1 XtalPi Inc. Company Details 11.3.2 XtalPi Inc. Business Overview 11.3.3 XtalPi Inc. Artificial Intelligence Drug Development Introduction 11.3.4 XtalPi Inc. Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.3.5 XtalPi Inc. Recent Developments 11.4 Exscientia Limited 11.4.1 Exscientia Limited Company Details 11.4.2 Exscientia Limited Business Overview 11.4.3 Exscientia Limited Artificial Intelligence Drug Development Introduction 11.4.4 Exscientia Limited Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.4.5 Exscientia Limited Recent Developments 11.5 AiCure, LLC 11.5.1 AiCure, LLC Company Details 11.5.2 AiCure, LLC Business Overview 11.5.3 AiCure, LLC Artificial Intelligence Drug Development Introduction 11.5.4 AiCure, LLC Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.5.5 AiCure, LLC Recent Developments 11.6 Atomwise 11.6.1 Atomwise Company Details 11.6.2 Atomwise Business Overview 11.6.3 Atomwise Artificial Intelligence Drug Development Introduction 11.6.4 Atomwise Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.6.5 Atomwise Recent Developments 11.7 Biovista Inc. 11.7.1 Biovista Inc. Company Details 11.7.2 Biovista Inc. Business Overview 11.7.3 Biovista Inc. Artificial Intelligence Drug Development Introduction 11.7.4 Biovista Inc. Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.7.5 Biovista Inc. Recent Developments 11.8 Breg,Inc. 11.8.1 Breg,Inc. Company Details 11.8.2 Breg,Inc. Business Overview 11.8.3 Breg,Inc. Artificial Intelligence Drug Development Introduction 11.8.4 Breg,Inc. Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.8.5 Breg,Inc. Recent Developments 11.9 Numerate 11.9.1 Numerate Company Details 11.9.2 Numerate Business Overview 11.9.3 Numerate Artificial Intelligence Drug Development Introduction 11.9.4 Numerate Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.9.5 Numerate Recent Developments 11.10 Cloud Pharmaceuticals 11.10.1 Cloud Pharmaceuticals Company Details 11.10.2 Cloud Pharmaceuticals Business Overview 11.10.3 Cloud Pharmaceuticals Artificial Intelligence Drug Development Introduction 11.10.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.10.5 Cloud Pharmaceuticals Recent Developments 11.11 IBM 11.11.1 IBM Company Details 11.11.2 IBM Business Overview 11.11.3 IBM Artificial Intelligence Drug Development Introduction 11.11.4 IBM Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.11.5 IBM Recent Developments 11.12 NuMedii 11.12.1 NuMedii Company Details 11.12.2 NuMedii Business Overview 11.12.3 NuMedii Artificial Intelligence Drug Development Introduction 11.12.4 NuMedii Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.12.5 NuMedii Recent Developments 11.13 BenevolentAI 11.13.1 BenevolentAI Company Details 11.13.2 BenevolentAI Business Overview 11.13.3 BenevolentAI Artificial Intelligence Drug Development Introduction 11.13.4 BenevolentAI Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.13.5 BenevolentAI Recent Developments 11.14 Lam Therapeutics 11.14.1 Lam Therapeutics Company Details 11.14.2 Lam Therapeutics Business Overview 11.14.3 Lam Therapeutics Artificial Intelligence Drug Development Introduction 11.14.4 Lam Therapeutics Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.14.5 Lam Therapeutics Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
SummaryMarket Analysis and Insights: Global Artificial Intelligence Drug Development Market Table of Contents1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Artificial Intelligence Drug Development Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 Drug Design 1.2.3 Drug Synthesis 1.2.4 Other 1.3 Market by Application 1.3.1 Global Artificial Intelligence Drug Development Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Tumor 1.3.3 Nervous System 1.3.4 Other 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Artificial Intelligence Drug Development Market Perspective (2018-2029) 2.2 Global Artificial Intelligence Drug Development Growth Trends by Region 2.2.1 Artificial Intelligence Drug Development Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Artificial Intelligence Drug Development Historic Market Size by Region (2018-2023) 2.2.3 Artificial Intelligence Drug Development Forecasted Market Size by Region (2024-2029) 2.3 Artificial Intelligence Drug Development Market Dynamics 2.3.1 Artificial Intelligence Drug Development Industry Trends 2.3.2 Artificial Intelligence Drug Development Market Drivers 2.3.3 Artificial Intelligence Drug Development Market Challenges 2.3.4 Artificial Intelligence Drug Development Market Restraints 3 Competition Landscape by Key Players 3.1 Global Revenue Artificial Intelligence Drug Development by Players 3.1.1 Global Artificial Intelligence Drug Development Revenue by Players (2018-2023) 3.1.2 Global Artificial Intelligence Drug Development Revenue Market Share by Players (2018-2023) 3.2 Global Artificial Intelligence Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Global Key Players of Artificial Intelligence Drug Development, Ranking by Revenue, 2021 VS 2022 VS 2023 3.4 Global Artificial Intelligence Drug Development Market Concentration Ratio 3.4.1 Global Artificial Intelligence Drug Development Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Drug Development Revenue in 2022 3.5 Global Key Players of Artificial Intelligence Drug Development Head office and Area Served 3.6 Global Key Players of Artificial Intelligence Drug Development, Product and Application 3.7 Global Key Players of Artificial Intelligence Drug Development, Date of Enter into This Industry 3.8 Mergers & Acquisitions, Expansion Plans 4 Artificial Intelligence Drug Development Breakdown Data by Type 4.1 Global Artificial Intelligence Drug Development Historic Market Size by Type (2018-2023) 4.2 Global Artificial Intelligence Drug Development Forecasted Market Size by Type (2024-2029) 5 Artificial Intelligence Drug Development Breakdown Data by Application 5.1 Global Artificial Intelligence Drug Development Historic Market Size by Application (2018-2023) 5.2 Global Artificial Intelligence Drug Development Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Artificial Intelligence Drug Development Market Size (2018-2029) 6.2 North America Artificial Intelligence Drug Development Market Size by Type 6.2.1 North America Artificial Intelligence Drug Development Market Size by Type (2018-2023) 6.2.2 North America Artificial Intelligence Drug Development Market Size by Type (2024-2029) 6.2.3 North America Artificial Intelligence Drug Development Market Share by Type (2018-2029) 6.3 North America Artificial Intelligence Drug Development Market Size by Application 6.3.1 North America Artificial Intelligence Drug Development Market Size by Application (2018-2023) 6.3.2 North America Artificial Intelligence Drug Development Market Size by Application (2024-2029) 6.3.3 North America Artificial Intelligence Drug Development Market Share by Application (2018-2029) 6.4 North America Artificial Intelligence Drug Development Market Size by Country 6.4.1 North America Artificial Intelligence Drug Development Market Size by Country: 2018 VS 2022 VS 2029 6.4.2 North America Artificial Intelligence Drug Development Market Size by Country (2018-2023) 6.4.3 North America Artificial Intelligence Drug Development Market Size by Country (2024-2029) 6.4.4 United States 6.4.5 Canada 7 Europe 7.1 Europe Artificial Intelligence Drug Development Market Size (2018-2029) 7.2 Europe Artificial Intelligence Drug Development Market Size by Type 7.2.1 Europe Artificial Intelligence Drug Development Market Size by Type (2018-2023) 7.2.2 Europe Artificial Intelligence Drug Development Market Size by Type (2024-2029) 7.2.3 Europe Artificial Intelligence Drug Development Market Share by Type (2018-2029) 7.3 Europe Artificial Intelligence Drug Development Market Size by Application 7.3.1 Europe Artificial Intelligence Drug Development Market Size by Application (2018-2023) 7.3.2 Europe Artificial Intelligence Drug Development Market Size by Application (2024-2029) 7.3.3 Europe Artificial Intelligence Drug Development Market Share by Application (2018-2029) 7.4 Europe Artificial Intelligence Drug Development Market Size by Country 7.4.1 Europe Artificial Intelligence Drug Development Market Size by Country: 2018 VS 2022 VS 2029 7.4.2 Europe Artificial Intelligence Drug Development Market Size by Country (2018-2023) 7.4.3 Europe Artificial Intelligence Drug Development Market Size by Country (2024-2029) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 China 8.1 China Artificial Intelligence Drug Development Market Size (2018-2029) 8.2 China Artificial Intelligence Drug Development Market Size by Type 8.2.1 China Artificial Intelligence Drug Development Market Size by Type (2018-2023) 8.2.2 China Artificial Intelligence Drug Development Market Size by Type (2024-2029) 8.2.3 China Artificial Intelligence Drug Development Market Share by Type (2018-2029) 8.3 China Artificial Intelligence Drug Development Market Size by Application 8.3.1 China Artificial Intelligence Drug Development Market Size by Application (2018-2023) 8.3.2 China Artificial Intelligence Drug Development Market Size by Application (2024-2029) 8.3.3 China Artificial Intelligence Drug Development Market Share by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia Artificial Intelligence Drug Development Market Size (2018-2029) 9.2 Asia Artificial Intelligence Drug Development Market Size by Type 9.2.1 Asia Artificial Intelligence Drug Development Market Size by Type (2018-2023) 9.2.2 Asia Artificial Intelligence Drug Development Market Size by Type (2024-2029) 9.2.3 Asia Artificial Intelligence Drug Development Market Share by Type (2018-2029) 9.3 Asia Artificial Intelligence Drug Development Market Size by Application 9.3.1 Asia Artificial Intelligence Drug Development Market Size by Application (2018-2023) 9.3.2 Asia Artificial Intelligence Drug Development Market Size by Application (2024-2029) 9.3.3 Asia Artificial Intelligence Drug Development Market Share by Application (2018-2029) 9.4 Asia Artificial Intelligence Drug Development Market Size by Region 9.4.1 Asia Artificial Intelligence Drug Development Market Size by Region: 2018 VS 2022 VS 2029 9.4.2 Asia Artificial Intelligence Drug Development Market Size by Region (2018-2023) 9.4.3 Asia Artificial Intelligence Drug Development Market Size by Region (2024-2029) 9.4.4 Japan 9.4.5 South Korea 9.4.6 China Taiwan 9.4.7 Southeast Asia 9.4.8 India 9.4.9 Australia 10 Middle East, Africa, and Latin America 10.1 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size (2018-2029) 10.2 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Type 10.2.1 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Type (2018-2023) 10.2.2 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Type (2024-2029) 10.2.3 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Share by Type (2018-2029) 10.3 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Application 10.3.1 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Application (2018-2023) 10.3.2 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Application (2024-2029) 10.3.3 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Share by Application (2018-2029) 10.4 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Country 10.4.1 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Country: 2018 VS 2022 VS 2029 10.4.2 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Country (2018-2023) 10.4.3 Middle East, Africa, and Latin America Artificial Intelligence Drug Development Market Size by Country (2024-2029) 10.4.4 Brazil 10.4.5 Mexico 10.4.6 Turkey 10.4.7 Saudi Arabia 10.4.8 Israel 10.4.9 GCC Countries 11 Key Players Profiles 11.1 Insilico Medicine 11.1.1 Insilico Medicine Company Details 11.1.2 Insilico Medicine Business Overview 11.1.3 Insilico Medicine Artificial Intelligence Drug Development Introduction 11.1.4 Insilico Medicine Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.1.5 Insilico Medicine Recent Developments 11.2 Cyclica 11.2.1 Cyclica Company Details 11.2.2 Cyclica Business Overview 11.2.3 Cyclica Artificial Intelligence Drug Development Introduction 11.2.4 Cyclica Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.2.5 Cyclica Recent Developments 11.3 XtalPi Inc. 11.3.1 XtalPi Inc. Company Details 11.3.2 XtalPi Inc. Business Overview 11.3.3 XtalPi Inc. Artificial Intelligence Drug Development Introduction 11.3.4 XtalPi Inc. Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.3.5 XtalPi Inc. Recent Developments 11.4 Exscientia Limited 11.4.1 Exscientia Limited Company Details 11.4.2 Exscientia Limited Business Overview 11.4.3 Exscientia Limited Artificial Intelligence Drug Development Introduction 11.4.4 Exscientia Limited Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.4.5 Exscientia Limited Recent Developments 11.5 AiCure, LLC 11.5.1 AiCure, LLC Company Details 11.5.2 AiCure, LLC Business Overview 11.5.3 AiCure, LLC Artificial Intelligence Drug Development Introduction 11.5.4 AiCure, LLC Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.5.5 AiCure, LLC Recent Developments 11.6 Atomwise 11.6.1 Atomwise Company Details 11.6.2 Atomwise Business Overview 11.6.3 Atomwise Artificial Intelligence Drug Development Introduction 11.6.4 Atomwise Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.6.5 Atomwise Recent Developments 11.7 Biovista Inc. 11.7.1 Biovista Inc. Company Details 11.7.2 Biovista Inc. Business Overview 11.7.3 Biovista Inc. Artificial Intelligence Drug Development Introduction 11.7.4 Biovista Inc. Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.7.5 Biovista Inc. Recent Developments 11.8 Breg,Inc. 11.8.1 Breg,Inc. Company Details 11.8.2 Breg,Inc. Business Overview 11.8.3 Breg,Inc. Artificial Intelligence Drug Development Introduction 11.8.4 Breg,Inc. Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.8.5 Breg,Inc. Recent Developments 11.9 Numerate 11.9.1 Numerate Company Details 11.9.2 Numerate Business Overview 11.9.3 Numerate Artificial Intelligence Drug Development Introduction 11.9.4 Numerate Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.9.5 Numerate Recent Developments 11.10 Cloud Pharmaceuticals 11.10.1 Cloud Pharmaceuticals Company Details 11.10.2 Cloud Pharmaceuticals Business Overview 11.10.3 Cloud Pharmaceuticals Artificial Intelligence Drug Development Introduction 11.10.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.10.5 Cloud Pharmaceuticals Recent Developments 11.11 IBM 11.11.1 IBM Company Details 11.11.2 IBM Business Overview 11.11.3 IBM Artificial Intelligence Drug Development Introduction 11.11.4 IBM Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.11.5 IBM Recent Developments 11.12 NuMedii 11.12.1 NuMedii Company Details 11.12.2 NuMedii Business Overview 11.12.3 NuMedii Artificial Intelligence Drug Development Introduction 11.12.4 NuMedii Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.12.5 NuMedii Recent Developments 11.13 BenevolentAI 11.13.1 BenevolentAI Company Details 11.13.2 BenevolentAI Business Overview 11.13.3 BenevolentAI Artificial Intelligence Drug Development Introduction 11.13.4 BenevolentAI Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.13.5 BenevolentAI Recent Developments 11.14 Lam Therapeutics 11.14.1 Lam Therapeutics Company Details 11.14.2 Lam Therapeutics Business Overview 11.14.3 Lam Therapeutics Artificial Intelligence Drug Development Introduction 11.14.4 Lam Therapeutics Revenue in Artificial Intelligence Drug Development Business (2018-2023) 11.14.5 Lam Therapeutics Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート本レポートと同じKEY WORD(artificial intelligence)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|